Bloodlines Series: Risk, Regimens, and Research for Multiple Myeloma
Multiple myeloma can be tricky to treat, but many treatment options exist, and new research is constantly supporting more.
Multiple myeloma can be tricky to treat, but many treatment options exist, and new research is constantly supporting more.
Natalie Snider-Hoy, a PhD candidate at Wayne State University, attended AACR Early-career Hill Day 2025 to advocate for sustained...
Cancer screenings are key to saving lives. Take colonoscopies, for example, which are estimated to reduce colorectal cancer risk...
The final day of AACR IO highlighted the emerging frontier of glyco-immunology.
The third keynote session at AACR IO highlighted exciting advances in CAR T-cell therapy, including for solid cancers.
The second keynote session at AACR IO focused on deciphering T-cell receptors, creating TCR libraries, and rewiring cytokine signaling.
To improve cancer outcomes among African Americans, open communication within families and the community is crucial to help break...
Immune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night...
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk,...
Researchers are examining ways to make treatments more targeted to each type of biliary tract cancer or to each...
Four past recipients of the Global Scholar-in-Training Award (GSITA) share how their experience at the AACR Annual Meeting impacted...